Menarini Philippines continue its thrust to promote its Community to Control PE advocacy campaign this 2015 with its Happy Wife, Happy Life event.
When it comes to sexual intimacy, couples need to be more open with their partners about what satisfies them.
Given that the two of you share a special bond, there’s no reason for you to not be comfortable about discussing what you like – and don’t like about sex. After all, an activity that is meant to be enjoyed, should provide fulfillment for both parties.
What is Premature Ejaculation (PE)
PE is the most common sexual dysfunction in men and is characterized by difficulty in controlling ejaculation. PE is recognized as a medical condition by global health organizations such as the World Health Organization (WHO), the International Society of Sexual Medicine (ISSM), and the European Association of Urology (EAU).Effective treatment of PE can not only improve control over ejaculation but also improve sexual satisfaction and overall quality of life for both men and their partners.
Click Premature Ejaculation Diagnostic Tool (PEDT Quiz) for a quick test
As such, Menarini Philippines together with the Philippine Urological Association, boldly launched its Commit to Control PE Advocacy campaign last year to address one of the more pressing issues regarding sexual intimacy – premature ejaculation.
The campaign is meant to make couples more comfortable about discussing their intimacy concerns with each other, without it being a cause of insecurity or dissatisfaction.
This is because premature ejaculation can gravely affect one’s relationship when left undiscussed – and untreated.
In relation to this, Menarini Philippines held a talk, aptly called Happy Wife, Happy Life, which was held last January 10 at the Satin Room of the Seda Hotels in BGC and was attended by local bloggers. It aimed to shed better insight about what premature ejaculation is all about, and that it is not something to be embarrassed about because it can be controlled.
The event was hosted by popular celebrity columnist RJ Ledesma and featured a very insightful talk from sex and relationship guru, Dr. Margie Holmes, concerning “the love that last is better”. Also present at the event was Dr. Dennis Serrano, who talked about the “basics” of premature ejaculation to help the guests have a better understanding of this condition.
Dr. Dennis Serrano bring us insights about premature ejaculation and even presented recent survey regarding the status of PE in Asia. He pointed out that PE is a treatable sexual dysfunction and Menarini had develop a medicine which is called Priligy (Dapoxetine).
Dapoxetine, marketed as Priligy (among and other brands), is the first compound developed specially for the treatment of premature ejaculation (PE) in men 18–64 years old. Dapoxetine works by inhibiting the serotonin transporter, increasing serotonin’s action at the post synaptic cleft, and as a consequence promoting ejaculatory delay. As a member of selective serotonin reuptake inhibitor (SSRI) family, dapoxetine was initially created as an antidepressant. However, unlike other SSRIs, dapoxetine is absorbed and eliminated rapidly in the body. Its fast acting property makes it suitable for the treatment of PE but not as an antidepressant.
Dapoxetine is available by prescription in 30 mg and 60 mg oral tablets.
While Dr. Margie Holmes, discussed about the “Love and Lust that Last”. She pointed out relevant and possible solutions to keep sexual intimacy for couples. She even stressed that that PE is not just a physiological problem affecting men, it is an issue that affects women silently, their relationships between partners, between husbands and wives. Acceptance and understanding the situation can resolve the issue particularly if they seek help from their doctors.
Menarini Philippines strongly believes in this advocacy which is often left untreated because it is a topic that is usually considered taboo even in these modern times. The pharmaceutical giant hopes to make a stronger impact among Filipino couples on their campaign this year with more events like this.
About the Menarini Group
Menarini is the world’s largest Italian biopharmaceutical company with a heritage of over 128 years and over 16,000 employees in over 100 countries. Here in Asia-Pacific, Menarini’s vision is to be a leading provider of important healthcare brands to improve the lives of people in the region. Menarini Asia-Pacific operates across the entire commercial value chain, from regulatory approval and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields, including Dermatology, Primary Care, Allergy/Respiratory, Cardiovascular, Select Specialty Care, Men’s Health and Consumer Health.